FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “ RenovoRx, Inc. Receives New 510(k) Clearance For RenovoCath Delivery System”
RenovoRx, Inc. (NASDAQ: RNXT) surged over 40% in premarket trading after the company announced that it had received a new 510(k) clearance from the U.S. FDA for its proprietary RenovoCath Delivery System.
The RenovoCath Delivery System is the device component of the Company’s initial product, RenovoGem™ and the new design provides more targeted delivery of therapy which the Company believes can translate into more effective treatment with fewer side effects.
RenovoRx, a biopharmaceutical company headquartered in Silicon Valley, California, has developed a therapy platform targeting difficult-to-treat tumors. Targeted therapy via the proprietary RenovoRx Trans-Arterial Micro-Perfusion (RenovoTAMP) platform safely and without transmission to non-targeted areas, is the primary focus.
For more information, please visit: RenovoRx, Inc.
About The Buzz: A Financial Buzz Show on daily news, covering the most up to date financial information. The Buzz intends to provide factual and relevant information for its audience. The Buzz is 100% original content, created by Financial Buzz Media. Located on Wall Street in the heart of New York City’s financial district, FinancialBuzz.com is a credible source for the world’s latest trending financial and economic news. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content.